Mechanistic evidence to support the anti-hepatitis b viral activity of multifunctional scaffold & conformationally restricted magnolol

National Academy Science Letters

Volumn 37, Issue 1, 2014, Pages 45-50

  Singla, Rajeev K ^a  

^a NETAJI SUBHAS INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Antihepatitis B viral activity; Docking studies; GRIP docking; Magnolol; Natural antiviral agent

Indexed keywords

EID: 84896750992     PISSN: 0250541X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s40009-013-0195-2     Document Type: Article

References (18)

1. Attrey DP, Singh AK, Katyal J et al (2012) Pharmacognostical characterization & preliminary phytochemical investigation of seabuckthorn (Hippophae rhamnoides L.) leaves. Indo Global J Pharm Sci 2(2):108-113
2. Antonelli G, Turriziani O (2012) Antiviral therapy: old and current issues. Int J Antimicrob Agents 40:95-102
3. Elion GB, Furman PA, Fyfe JA et al (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716-5720
4. Fyfe JA, Keller PM, Furman PA et al (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2- hydroxyethoxymethyl) guanine. J Biol Chem 253:8721-8727
5. Talwar GP, Dar SA, Rai MK et al (2008) A novel polyherbal microbiocide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int J Antimicrob Agents 32:180-185
6. Li J, Huang Y, Guan XL et al (2012) Anti-hepatitis B virus constituents from the stem bark of Streblus asper. Phytochemistry 82:100-109
7. Castilla V, Barquero AA, Mersich SE et al (1998) In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves. Int J Antimicrob Agents 10:67-75
8. Chen YH, Huang PH, Lin FY et al (2011) Magnolol: a multifunction compound isolated from the Chinese medicinal plant Magnolia officinalis. Eur J Integr Med 3:e317-e324
9. Shen Y, Zhukovskaya NL, Zimmer MI et al (2004) Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci USA 101:3242-3247
10. Sabini E, Hazra S, Konrad M et al (2007) Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res 35:186-192
11. Koch K, Chen YX, Feng JY et al (2009) Nucleoside diphosphate kinase and the activation of antiviral phosphonate analogs of nucleotides: binding mode and phosphorylation of tenofovir derivatives. Nucleosides, Nucleotides Nucleic Acids 28:776-792
12. Wynne SA, Crowther RA, Leslie AG (1999) The crystal structure of the human hepatitis B virus capsid. Mol Cell 3:771-780
13. Garcia-Saez I, Lacroix FB, Blot D et al (2011) Structural characterization of HBXIP: the protein that interacts with the anti-apoptotic protein survivin and the oncogenic viral protein HBx. Mol Biol 405:331-340
14. Singla RK, Bhat VG (2010) QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans. J Enzyme Inhib Med Chem 25(5):696-701
15. Malleshappa NN, Patel HM (2011) A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: a rationale approach to anticancer drug design. J Saudi Chem Soc. doi: 10.1016/j.jscs.2011.04.017
16. Bhuva HA, Kini SG (2010) Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitor. J Mol Graph Model 29:32-37
17. VLifeMDS: Molecular Design Suite (2010) VLife Sciences Technologies Pvt. Ltd., Pune, India. (www.vlifesciences.com)
18. Hazra S, Szewczak A, Ort S et al (2011) Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release. Biochemistry 50(14):2870-2880